Wilmington Savings Fund Society FSB Makes New Investment in Mettler-Toledo International Inc. (NYSE:MTD)

Wilmington Savings Fund Society FSB purchased a new position in shares of Mettler-Toledo International Inc. (NYSE:MTD) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 74 shares of the medical instruments supplier’s stock, valued at approximately $111,000.

A number of other institutional investors have also made changes to their positions in the business. UMB Bank n.a. raised its holdings in Mettler-Toledo International by 6.6% during the second quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier’s stock worth $158,000 after acquiring an additional 7 shares in the last quarter. DT Investment Partners LLC raised its stake in shares of Mettler-Toledo International by 13.3% during the 3rd quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock worth $102,000 after purchasing an additional 8 shares in the last quarter. Suncoast Equity Management boosted its holdings in shares of Mettler-Toledo International by 2.0% in the 3rd quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier’s stock valued at $690,000 after buying an additional 9 shares during the last quarter. Bleakley Financial Group LLC boosted its holdings in shares of Mettler-Toledo International by 1.2% in the 3rd quarter. Bleakley Financial Group LLC now owns 757 shares of the medical instruments supplier’s stock valued at $1,135,000 after buying an additional 9 shares during the last quarter. Finally, Huntington National Bank grew its stake in shares of Mettler-Toledo International by 20.0% in the third quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after buying an additional 9 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on MTD. Wells Fargo & Company dropped their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Evercore ISI raised their target price on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Wolfe Research assumed coverage on Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating for the company. Robert W. Baird dropped their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research note on Monday, November 11th. Finally, Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and lifted their target price for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Mettler-Toledo International has a consensus rating of “Hold” and a consensus price target of $1,351.25.

Mettler-Toledo International Stock Performance

MTD opened at $1,206.02 on Friday. The stock has a fifty day moving average of $1,288.23 and a 200-day moving average of $1,372.15. Mettler-Toledo International Inc. has a fifty-two week low of $1,115.64 and a fifty-two week high of $1,546.93. The company has a market capitalization of $25.45 billion, a P/E ratio of 32.52, a P/E/G ratio of 4.19 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The business had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. On average, equities research analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other news, insider Gerry Keller sold 140 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the transaction, the insider now directly owns 6 shares in the company, valued at approximately $7,524.54. The trade was a 95.89 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares in the company, valued at $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by corporate insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.